Health Press Release – Newsletter for March 10, 2011

Elsevier Announces the Anxiety and Depression: 21st Neuropharmacology Conference

OXFORD, England, March 9, 2011 – Elsevier, the leading publisher of scientific, technical and medical
information products and services, today announced that the Anxiety and
Depression: 21st Neuropharmacology Annual Conference will take place in
Virginia, USA on 10-11 November 2011 as a satellite to the 2011 Meeting of
the Society for Neuroscience.

Anxiety and depression … Read more >>>.

2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery

Management of Antiplatelet Drug Therapy Important to Quality Improvement
SAN DIEGO, March 9, 2011 – Accumetrics, Inc., a privately-held developer and marketer of the
VerifyNow(R) System, the first rapid and easy-to-use point-of-care system for
measuring platelet reactivity to multiple antiplatelet agents, announced
today that new Guidelines were recently published in The Annals of Thoracic
Surgery that include point-of-care testing … Read more >>.

Simbionix Welcomes New Vice President for US Business Development

CLEVELAND, March 9, 2011 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation training products for medical professionals and the
healthcare industry, is pleased to announce that William Lewandowski has been
promoted to the position of VP for US Business Development.

Mr. Lewandowski has over 21 years of experience in … Read the original article on Gaea Times at : Simbionix Welcomes New Vice President for US Business Development.

NextGen Sciences Completes Biomarker Business Refocus

ANN ARBOR, Michigan, and LONDON, March 9, 2011 – NextGen Group plc (AIM:NGG) is pleased to announce that its
subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement
and qualification, has completed a commercial reorganization. The
restructuring, which is accompanied by new management appointments, is
expected to help the company execute its strategy of becoming a leading
player …. Original source  : NextGen Sciences Completes Biomarker Business Refocus.